Harrison_2006_Naunyn.Schmiedebergs.Arch.Pharmacol_373_230

Reference

Title : The presence of atropinesterase activity in animal plasma - Harrison_2006_Naunyn.Schmiedebergs.Arch.Pharmacol_373_230
Author(s) : Harrison PK , Tattersall JE , Gosden E
Ref : Naunyn Schmiedebergs Arch Pharmacol , 373 :230 , 2006
Abstract : The enzyme atropinesterase (EC 3.1.1.10) causes the rapid hydrolysis of tropane alkaloids such as atropine and scopolamine. This enzyme is known to occur in a certain proportion of rabbits and some plants, although its presence in other animal species remains controversial. The potential presence in some animals but not others of an enzyme which can rapidly hydrolyse compounds such as atropine is a potential unwanted experimental variable in many experiments. Because of the uncertainty surrounding the enzyme and the paucity of data, it was decided to examine whether we could detect and characterise atropinesterase activity in the plasma of dogs, goats, guinea-pigs, humans, pigs, rabbits and rhesus by separating and quantitating the substrate (atropine) and one of the products (tropic acid) by high performance liquid chromatography (HPLC). It was found that plasma from some but not all rabbits possessed a capacity to breakdown large quantities of atropine; an effect that was apparently enantiomer-specific. Plasma from other rabbits, and plasma from all other species investigated, proved capable of hydrolysing atropine at a rate exceeding that of non-specific breakdown. It remains to be determined whether this effect is due to a low expression of atropinesterase or an alternative hydrolysing enzyme.
ESTHER : Harrison_2006_Naunyn.Schmiedebergs.Arch.Pharmacol_373_230
PubMedSearch : Harrison_2006_Naunyn.Schmiedebergs.Arch.Pharmacol_373_230
PubMedID: 16736160

Related information

Citations formats

Harrison PK, Tattersall JE, Gosden E (2006)
The presence of atropinesterase activity in animal plasma
Naunyn Schmiedebergs Arch Pharmacol 373 :230

Harrison PK, Tattersall JE, Gosden E (2006)
Naunyn Schmiedebergs Arch Pharmacol 373 :230